We confirmed our results further through confocal microscopy, which showed an increased immunoreactivity of GFAP and Iba1 in the striatum and SNpc of PD mouse models, while Trolox treatment substantially decreased this expression (Figure 5b,c). Here, GFAP is linked to Parkinson disease.